About
Samira Kiani is a synthetic biology and gene-editing researcher active in longevity and immunology-related biotech. HexemBio's official materials list her as CTO and co-founder, while GenexGen lists her as co-founder and scientific advisor. Public profiles also describe her as a science communicator and University of Pittsburgh faculty member working on CRISPR, epigenetic control, and programmable immune therapies.
Areas of interest
longevitybiotechregenerative medicinestem cellshematologysynthetic biologyCRISPRgene editingepigenetic therapiesimmunologycell therapyvaccinationbioengineeringscience communicationAI in biotech